Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Samama

Showing results (181-190 of 677) with videos related to

Pageof 68
Sort By:
Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology|January 1, 1979
Blood coagulation and platelet function: introductionB B Vargaftig, J Conard, M Samama
Journal Des Maladies Vasculaires|November 1, 1996
[Forensic medical implications of anticoagulant treatments]M Samama, J C Valdes, J Natali
British Journal of Haematology|March 2, 1999
Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgeryL Bara, A Planes, M M Samama
International Angiology : a Journal of the International Union of Angiology|March 1, 1995
Red cell aggregability increases with the severity of venous insufficiencyA Chabanel, F Zuccarelli, M M Samama
Thrombosis Research|September 1, 1991
Importance of plasminogen activator inhibitor type 1 (PAI-1) for preventing single chain urokinase plasminogen activator (scu-PA) conversion into two chain urokinase plasminogen activator (tcu-PA) in plasma in vitroA M Dosne, F Dubor, M Samama
Annales De Medecine Interne|January 1, 1986
[Treatment of deep venous thromboses with heparin. Therapeutic management and biological monitoring]J Conard, M H Horellou, M Samama
Acta Chirurgica Scandinavica. Supplementum|January 1, 1988
Incidence of thromboembolism in association with congenital disorders in coagulation and fibrinolysisJ Conard, M H Horellou, M Samama
Annales De Biologie Clinique|October 7, 2000
[Follow-up of the treatment by direct thrombin inhibitors: activated partial thromboplastin time or ecarin clotting time]A Kher, I Gouin, M M Samama
Thrombosis and Haemostasis|February 15, 1979
Urokinase i and ii activityM Samama, B Cazenave, A M Otero
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 1, 1995
[Current biological surveillance of oral anticoagulant treatment]G Helft, A Vacheron, M M Samama
Pageof 68

Showing results (181-190 of 677) with videos related to

Sort By:
Pageof 68
Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology|January 1, 1979
Blood coagulation and platelet function: introductionB B Vargaftig, J Conard, M Samama
Journal Des Maladies Vasculaires|November 1, 1996
[Forensic medical implications of anticoagulant treatments]M Samama, J C Valdes, J Natali
British Journal of Haematology|March 2, 1999
Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgeryL Bara, A Planes, M M Samama
International Angiology : a Journal of the International Union of Angiology|March 1, 1995
Red cell aggregability increases with the severity of venous insufficiencyA Chabanel, F Zuccarelli, M M Samama
Thrombosis Research|September 1, 1991
Importance of plasminogen activator inhibitor type 1 (PAI-1) for preventing single chain urokinase plasminogen activator (scu-PA) conversion into two chain urokinase plasminogen activator (tcu-PA) in plasma in vitroA M Dosne, F Dubor, M Samama
Annales De Medecine Interne|January 1, 1986
[Treatment of deep venous thromboses with heparin. Therapeutic management and biological monitoring]J Conard, M H Horellou, M Samama
Acta Chirurgica Scandinavica. Supplementum|January 1, 1988
Incidence of thromboembolism in association with congenital disorders in coagulation and fibrinolysisJ Conard, M H Horellou, M Samama
Annales De Biologie Clinique|October 7, 2000
[Follow-up of the treatment by direct thrombin inhibitors: activated partial thromboplastin time or ecarin clotting time]A Kher, I Gouin, M M Samama
Thrombosis and Haemostasis|February 15, 1979
Urokinase i and ii activityM Samama, B Cazenave, A M Otero
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 1, 1995
[Current biological surveillance of oral anticoagulant treatment]G Helft, A Vacheron, M M Samama
Pageof 68